Thyroid cancer

Open Access
Evaluation of Altered Myocardial Blood Flow and Cardiovascular Function in Patients With Thyroid Cancer and Related Treatments
DANIEL HUENG-YUAN SHEN, HUNG-PIN CHAN, CHIN HU, WEN-HWA WANG, YU-LI CHIU and FU-REN TSAI

In Vivo September 2025, 39 (5) 2919-2930; DOI: https://doi.org/10.21873/invivo.14092
Open Access
RXRG as a Novel Biomarker and its Correlation With Immune Infiltration in Thyroid Carcinoma
PENGZHAO SONG, TIANQI CHEN, PENGFEI GU, YAHUI SUN and YONG HAN

In Vivo July 2025, 39 (4) 2013-2034; DOI: https://doi.org/10.21873/invivo.13998
Open Access
Thyroiditis and Thyroid Cancer: Bioinformatics Analysis of Gene Expression Data
SZU-I YU, YU-KANG CHANG, MEEI-LING SHEU and YAO-HSIEN TSENG

In Vivo September 2024, 38 (5) 2205-2213; DOI: https://doi.org/10.21873/invivo.13684
Open Access
Vitamin D Status and VDR Polymorphisms as Prognostic Factors in Differentiated Thyroid Carcinoma
ANDRA-MARIA COCOLOS, ANDREI MURESAN, ANDRA CARAGHEORGHEOPOL, MIRCEA GHEMIGIAN, DUMITRU IOACHIM and CATALINA POIANA

In Vivo September 2022, 36 (5) 2434-2441; DOI: https://doi.org/10.21873/invivo.12977
You have access
IGF Bioregulation System in Benign and Malignant Thyroid Nodular Disease: A Systematic Review
APOSTOLOS KARAGIANNIS, EVA KASSI, ANTONIOS CHATZIGEORGIOU and MICHAEL KOUTSILIERIS

In Vivo November 2020, 34 (6) 3069-3091; DOI: https://doi.org/10.21873/invivo.12141
You have access
Sequential Analysis of Neutrophil-to-lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib
NAOKI FUKUDA, XIAOFEI WANG, AKIHIRO OHMOTO, TETSUYA URASAKI, YASUYOSHI SATO, KENJI NAKANO, MASATOSHI NISHIZAWA, MAYU YUNOKAWA, MAKIKO ONO, JUNICHI TOMOMATSU and SHUNJI TAKAHASHI

In Vivo March 2020, 34 (2) 709-714; DOI: https://doi.org/10.21873/invivo.11828
You have access
Sodium Selenite Enhanced the Anti-proliferative Effect of MEK-ERK Inhibitor in Thyroid Cancer Cells
JONG BIN KIM, EUN YEOL YANG, JOOHYUN WOO, HYUNGJU KWON, WOOSUNG LIM and BYUNG-IN MOON

In Vivo January 2020, 34 (1) 185-190; DOI: https://doi.org/10.21873/invivo.11760
You have access
EZH2 Overexpression as a Useful Prognostic Marker for Aggressive Behaviour in Thyroid Cancer
KATSUHIKO MASUDO, NOBUYASU SUGANUMA, HIROTAKA NAKAYAMA, TAKASHI OSHIMA, YASUSHI RINO, HIROYUKI IWASAKI, KENICHI MATSUZU, KIMINORI SUGINO, KOICHI ITO, TETSUO KONDO, YOSHIYASU NAKAMURA, MITSUYO YOSHIHARA, MUNETAKA MASUDA and YOHEI MIYAGI

In Vivo January 2018, 32 (1) 25-31;

Main menu

User menu

Search

Thyroid cancer